Corticosteroids and cataracts

GL Spaeth, L von Sallmann - International Ophthalmology Clinics, 1966 - journals.lww.com
The prevalence of PSCC in the general population may be estimated with fair accuracy.
Considering only patients 65 years of age or older, 0.3 percent of the hospital beds of Great …

Eye and corticosteroid's use

A Fel, E Aslangul, C Le Jeunne - Presse Medicale (Paris, France …, 2012 - europepmc.org
Most common side effects of systemic corticosteroids are posterior subcapsular cataract and
glaucoma. There is no way to prevent corticosteroid-induced cataract. The risk of these …

[HTML][HTML] Prevalence of steroid-induced cataract and glaucoma in chronic obstructive pulmonary disease patients attending a tertiary care center in India

T Nath, SS Roy, H Kumar, R Agrawal, S Kumar… - Asia-Pacific Journal of …, 2017 - Elsevier
Purpose: Exposure to corticosteroids is known to be associated with an increased risk of
cataract and glaucoma. This study was undertaken to determine the prevalence of steroid …

Corticosteroid-induced cataracts

RC Urban Jr, E Cotlier - Survey of ophthalmology, 1986 - Elsevier
The association linking corticosteroid therapy with the development of posterior subcapsular
cataracts has been well documented. These drugs are widely used therapeutically …

Corticosteroid-induced glaucoma and cataracts in contact lens wearers

RM Burde, B Becker - JAMA, 1970 - jamanetwork.com
The indiscriminate topical application of corticosteroids to the eyes of two young patients
induced cataracts and glaucoma with permanent visual defects. Individuals with a high …

What causes steroid cataracts? A review of steroid‐induced posterior subcapsular cataracts

AI Jobling, RC Augusteyn - Clinical and experimental …, 2002 - Wiley Online Library
Prolonged use of glucocorticoids is a significant risk factor for the development of posterior
subcapsular cataract. This places restrictions on the use of glucocorticoids in the treatment …

Locally administered ocular corticosteroids: benefits and risks

CNJ McGhee, S Dean, H Danesh-Meyer - Drug Safety, 2002 - Springer
Corticosteroids, used prudently, are one of the most potent and effective modalities available
in the treatment of ocular inflammation. However, they can produce a plethora of adverse …

Posterior subcapsular cataract and inhaled corticosteroid therapy.

F Abuekteish, JN Kirkpatrick, G Russell - Thorax, 1995 - thorax.bmj.com
BACKGROUND--Although posterior subcapsular cataract complicates both systemic and
topical corticosteroid therapy, the literature on the effects of inhaled corticosteroids is …

Topical corticosteroids in atopic dermatitis and the risk of glaucoma and cataracts

IM Haeck, TJ Rouwen, L Timmer-de Mik… - Journal of the American …, 2011 - Elsevier
INTRODUCTION: There is concern about the development of glaucoma and cataracts
associated with topical corticosteroid use in patients with atopic dermatitis (AD) …

Cataract and ocular hypertension in children on inhaled corticosteroid therapy

AH Behbehani, AF Owayed, ZM Hijazi… - Journal of Pediatric …, 2005 - journals.healio.com
Purpose: To ascertain the incidence of posterior subcapsular cataract and ocular
hypertension in a cohort of children⩽ 12 years on inhaled steroid therapy. Patients and …